author-photo

Christine Terré

Versailles Saint-Quentin-en-Yvelines University

122

Papers

3781

Citations

Citation Trend

Filter By

Papers (88) Sort By

Journal Conference Others

KMT2A-ARHGEF12, a Therapy Related Fusion with Dismal Prognosis.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Replacing the Anthracycline By Gemtuzumab Ozogamicin in Older Patients with De Novo Standard-Risk Acute Myeloid Leukemia Treated Intensively – Results of the Randomized ALFA1401-Mylofrance 4 Study

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Early Detection of WT1 Measurable Residual Disease Identifies High-Risk Patients Independently of Transplantation in AML.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AML.

2021 Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML, an ALFA study

2021 Blood
Show All
- Source
- Cite
- Save
Citations (5)
Genetic Identification of AML Patients Older than 60 years Achieving Long-term Survival with Intensive Chemotherapy.

2021 Blood
Show All
- Source
- Cite
- Save
Citations (4)
Cryptic insertion of KMT2A, a rare t(9;11) variant.

2021 Blood
- Nada Assaf
- Christine Terré
Show All
- Source
- Cite
- Save
Citations (0)
A Personalized Approach to Guide Allogeneic Stem Cell Transplantation in Younger Adults with Acute Myeloid Leukemia.

2020 Blood
Show All
- Source
- Cite
- Save
Citations (9)
Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results.

2020 Blood Advances
Show All
- Source
- Cite
- Save
Citations (11)